01 July 2025
01 July 2025
AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous counterparts.
WHO director Dr Tedros Adhanom Ghebreyesus says all hypotheses are on the table, as the organisation works to reinforce future pandemic defences.
Gammagard liquid ERC is approved under the brand name Deqsiga by the European Medicines Agency.
The Riverview, Michigan site is expected to be operational by the end of 2025.
The planned 160,000ft² will focus on aseptic production and includes areas for material preparation and compounding.
GlobalData forecasts the US to remain as the leading market throughout the forecast period.
The FDA approval was based on the pooled data from two pivotal studies: the EMERALD trial and NI-0501-06.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
